Page Section: Left Content Column
Page Section: Centre Content Column
GP overstated benefits of a treatment for chronic fatigue syndrome (01HDC02649)
Download GP overstated benefits of a treatment for chronic fatigue syndrome (01HDC02649) (PDF 12Kb)
(01HDC02649, 17 December 2001)
Right to services of an
appropriate standard ~ Reasonable care and skill ~ Right
to be fully informed ~ Explanation of condition ~
Information about treatment options ~ General
practitioner ~ Chronic fatigue syndrome ~ Patient
monitoring ~ Right 4(1) ~ Right 6(1)(a) ~ Right
6(1)(b)
A complaint was made by a woman
about the services provided by a general practitioner on the basis
that the GP (1) provided Interval Hypoxic Training (IHT) to treat
her chronic fatigue syndrome (CFS); (2) informed her that IHT was
scientifically proven to treat CFS when it was not; and (3) did not
monitor her oxygen levels during the IHT treatments.
After obtaining independent expert
advice from a GP with a specialist qualification in sports
medicine, the Commissioner held that the GP did not breach Right
4(1) because he generally met the expected standards of care for a
GP when he provided IHT. Although not absolutely essential, it was
highly desirable to monitor oxygen levels with an oximeter during
each IHT treatment, particularly when using it to manage disease as
opposed to a training adjunct for healthy athletes. There was
evidence that the GP monitored the patient's oxygen levels during
the treatment apart from one occasion.
The Commissioner noted that the
efficacy of IHT was not in issue, as he does not have the power to
review the effectiveness of any treatment. The Code governs the
standard of treatment and information disclosed prior to treatment,
but not the efficacy of treatment. He commented that there is
nothing to prevent people providing or seeking out any form of
treatment they wish.
However, the Commissioner held that
the GP breached Right 6(1)(b) as he overstated the benefits of IHT
and led the patient to believe it was a scientifically proven
treatment for CFS. The lasting impression given to the patient, in
particular by the information sheet, was that IHT had significantly
proven benefits as a treatment for CFS. Therefore the GP did not
meet the standard of accurate information about benefits of a
proposed treatment that a reasonable patient in such circumstances
would expect to receive.
Page Section: Right Content Column
Top of Page